Aprogen pharmaceuticals,Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 14,665.67 million compared to KRW 13,412.18 million a year ago. Net income was KRW 2,685.71 million compared to KRW 4,537.82 million a year ago. Basic earnings per share from continuing operations was KRW 7 compared to KRW 12 a year ago. Diluted earnings per share from continuing operations was KRW 7 compared to KRW 12 a year ago. Basic earnings per share was KRW 7 compared to KRW 12 a year ago.
For the nine months, sales was KRW 733.48 million compared to KRW 2,463.32 million a year ago. Net income was KRW 6,322.39 million compared to KRW 12,102.8 million a year ago. Basic earnings per share from continuing operations was KRW 16 compared to KRW 42 a year ago. Diluted earnings per share from continuing operations was KRW 16 compared to KRW 42 a year ago. Basic earnings per share was KRW 16 compared to KRW 42 a year ago.